Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Basic Clin Pharmacol Toxicol ; 96(2): 111-7, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15679473

RESUMO

The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime (24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals (10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the following order: monocrotophos > heptenophos > dichlorvos. Administration of the oxime produced a significant reactivation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of monocrotophos-inhibited acetylcholinesterase in any of the tissues tested. These organophosphorus compounds produced a significant inhibition of plasma carboxylesterase activity, while administration of trimedoxime led to regeneration of the enzyme activity. The same dose of trimedoxime assured survival of experimental animals poisoned by all three organophosphorus compounds, although the biochemical findings were quite different.


Assuntos
Diclorvós/intoxicação , Monocrotofós/intoxicação , Intoxicação por Organofosfatos , Trimedoxima/uso terapêutico , Acetilcolina/química , Acetilcolina/metabolismo , Animais , Química Encefálica/efeitos dos fármacos , Carboxilesterase/antagonistas & inibidores , Carboxilesterase/sangue , Carboxilesterase/efeitos dos fármacos , Diafragma/efeitos dos fármacos , Diafragma/fisiologia , Diclorvós/administração & dosagem , Diclorvós/antagonistas & inibidores , Avaliação Pré-Clínica de Medicamentos/métodos , Eritrócitos/química , Eritrócitos/efeitos dos fármacos , Eritrócitos/fisiologia , Injeções Intravenosas , Dose Letal Mediana , Masculino , Camundongos , Monocrotofós/administração & dosagem , Monocrotofós/antagonistas & inibidores , Compostos Organofosforados/administração & dosagem , Compostos Organofosforados/antagonistas & inibidores , Oximas/administração & dosagem , Oximas/farmacologia , Oximas/uso terapêutico , Fatores de Tempo , Trimedoxima/administração & dosagem , Trimedoxima/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA